Emcure Pharmaceuticals Statistics

Total Valuation

BOM:544210 has a market cap or net worth of INR 248.71 billion. The enterprise value is 258.48 billion.

Market Cap	248.71B
Enterprise Value	258.48B

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	189.51M
Shares Outstanding	n/a
Shares Change (YoY)	+3.40%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	20.41M

Valuation Ratios

The trailing PE ratio is 36.50 and the forward PE ratio is 26.62.

PE Ratio	36.50
Forward PE	26.62
PS Ratio	3.15
PB Ratio	5.36
P/TBV Ratio	7.11
P/FCF Ratio	39.48
P/OCF Ratio	29.20
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.60, with an EV/FCF ratio of 41.03.

EV / Earnings	37.94
EV / Sales	3.27
EV / EBITDA	17.60
EV / EBIT	23.83
EV / FCF	41.03

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.22.

Current Ratio	1.71
Quick Ratio	0.86
Debt / Equity	0.22
Debt / EBITDA	0.70
Debt / FCF	1.62
Interest Coverage	6.17

Financial Efficiency

Return on equity (ROE) is 18.23% and return on invested capital (ROIC) is 12.19%.

Return on Equity (ROE)	18.23%
Return on Assets (ROA)	8.45%
Return on Invested Capital (ROIC)	12.19%
Return on Capital Employed (ROCE)	19.49%
Revenue Per Employee	7.28M
Profits Per Employee	627,840
Employee Count	10,852
Asset Turnover	0.98
Inventory Turnover	1.79

Taxes

In the past 12 months, BOM:544210 has paid 2.64 billion in taxes.

Income Tax	2.64B
Effective Tax Rate	27.17%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1,163.23
200-Day Moving Average	1,259.25
Relative Strength Index (RSI)	56.76
Average Volume (20 Days)	29,680

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544210 had revenue of INR 78.96 billion and earned 6.81 billion in profits. Earnings per share was 36.43.

Revenue	78.96B
Gross Profit	47.49B
Operating Income	10.85B
Pretax Income	9.71B
Net Income	6.81B
EBITDA	14.69B
EBIT	10.85B
Earnings Per Share (EPS)	36.43

Full Income Statement

Balance Sheet

The company has 2.41 billion in cash and 10.23 billion in debt, giving a net cash position of -7.81 billion.

Cash & Cash Equivalents	2.41B
Total Debt	10.23B
Net Cash	-7.81B
Net Cash Per Share	n/a
Equity (Book Value)	46.42B
Book Value Per Share	234.60
Working Capital	18.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.52 billion and capital expenditures -2.22 billion, giving a free cash flow of 6.30 billion.

Operating Cash Flow	8.52B
Capital Expenditures	-2.22B
Free Cash Flow	6.30B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.15%, with operating and profit margins of 13.74% and 8.63%.

Gross Margin	60.15%
Operating Margin	13.74%
Pretax Margin	12.30%
Profit Margin	8.63%
EBITDA Margin	18.60%
EBIT Margin	13.74%
FCF Margin	7.98%

Dividends & Yields

BOM:544210 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.40%
Shareholder Yield	n/a
Earnings Yield	2.74%
FCF Yield	2.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7